17-Hydroxyprogesterone
The 17-hydroxyprogesterone (17-OHP) test measures a hormone produced by the adrenal glands to screen for and diagnose congenital adrenal hyperplasia (CAH).
Overview
17-hydroxyprogesterone (17-OHP) is a substance produced by your adrenal glands, which are small organs located on top of each kidney. Normally, the body uses 17-OHP to produce cortisol, a hormone essential for controlling energy, blood pressure, and stress responses. Congenital adrenal hyperplasia (CAH) is a group of inherited disorders where the adrenal glands lack an enzyme (most commonly 21-hydroxylase) needed to make cortisol. This leads to enlarged adrenal glands and abnormally high levels of 17-OHP.
What is it used for?
The 17-OHP test is used to:
- Screen newborns for severe (classic) CAH.
- Diagnose mild (nonclassic) CAH in children, teens, and adults.
- Monitor the effectiveness of CAH treatment.
- Rule out CAH in women experiencing symptoms like facial hair or irregular periods.
Why do I need a 17-OHP test?
Newborns: Routine screening is performed shortly after birth to detect severe CAH, which can be life-threatening if untreated. Symptoms include dehydration, vomiting, diarrhea, and failure to thrive.
Children, Teens, and Adults: Testing may be necessary if symptoms of mild CAH appear, such as:
- Girls/Women: Excess facial/body hair, irregular periods, thinning hair, or infertility.
- Boys/Men: Enlarged penis with small testicles, low sperm count, or infertility.
- General: Early puberty, rapid growth followed by short stature, or severe acne.
What happens during the test?
- Newborns: A professional cleans the baby's heel and uses a small needle to collect a few drops of blood.
- Older children/Adults: A standard blood sample is drawn from a vein in the arm.
What do the results mean?
- Normal levels: It is unlikely that you or your child has CAH caused by 21-hydroxylase deficiency.
- High levels: Suggests the presence of CAH. Your provider may order further testing.
- Decreasing levels: If you are already being treated for CAH, a decrease in 17-OHP levels indicates that the treatment is working.
If results are unclear, a provider may order an ACTH stimulation test, which measures how your adrenal glands respond to an injection of ACTH hormone.